Phase I trial of oncolytic adenovirus-mediated cytotoxic and interleukin-12 gene therapy for the treatment of metastatic pancreatic cancer

Cited by papers we hold 3

• Targeting cytokine and chemokine signaling pathways for cancer therapy · 2024
  No notice
• Oncolytic virotherapy: basic principles, recent advances and future directions · 2023
  No notice
• Emerging strategies in targeting tumor-resident myeloid cells for cancer immunotherapy · 2022
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.